1

Vitaeris

Drug development immunology

www.vitaerisbio.com

HBM contact: Dr Andreas Wicki

Company status: private

Clinical stage company developing Clazakizumab, an anti IL-6 mAb for several immunological driven diseases such as kidney transplantation
 

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171